Search Results

filter by

diseases

news type

event type

topic type

location-search

date range filter – slider
1999 — 2025

Colombia becomes first country to recommend rapid tests to diagnose Chagas disease

New technical guidelines from Colombia's National Institute of Health based on research supported by DNDi will enable earlier treatment of Chagas disease nationwide.

New technical guidelines from Colombia's National Institute of Health based on research supported by DNDi will enable earlier treatment of Chagas disease nationwide.

  • Press releases
Chagas-Colombia-RapidTests-202505-01

Colombia becomes first country to recommend rapid tests to diagnose Chagas disease

New technical guidelines from Colombia's National Institute of Health based on research supported by DNDi will enable earlier treatment of Chagas disease nationwide.

New technical guidelines from Colombia's National Institute of Health based on research supported by DNDi will enable earlier treatment of Chagas disease nationwide.

  • Press releases
Chagas-Colombia-RapidTests-202505-01

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Over the 18-month project that was started in March 2025, Kitasato University, Nagasaki University, the University of Tokyo, and DNDi will utilize their expertise to identify at least five novel compounds derived from natural products with the potential to become medicines against Chagas.
  • Press releases
Woman walking in a laboratory

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Over the 18-month project that was started in March 2025, Kitasato University, Nagasaki University, the University of Tokyo, and DNDi will utilize their expertise to identify at least five novel compounds derived from natural products with the potential to become medicines against Chagas.
  • Press releases
Woman walking in a laboratory

Drug discovery explained: Chagas – How to prove treatments work?

Chagas disease: A breakthrough method to address the longstanding biomarkers challenge. DNDi researcher and series host Fanny Escudié explains how scientists are using the most advanced technologies to improve the lives of millions of neglected patients around the world.
  • Stories
Lab activities

Drug discovery explained: Chagas – How to prove treatments work?

Chagas disease: A breakthrough method to address the longstanding biomarkers challenge. DNDi researcher and series host Fanny Escudié explains how scientists are using the most advanced technologies to improve the lives of millions of neglected patients around the world.
  • Stories
Lab activities

DNDi supporting a pioneering project that integrates Indigenous knowledge in the treatment of Chagas

The innovation lies in the coordination and participation of Indigenous leaders and local health authorities to implement the treatment strategies.

The innovation lies in the coordination and participation of Indigenous leaders and local health authorities to implement the treatment strategies

  • Stories
PaedsFilm2024-ValleduparColombia-202409-30

DNDi supporting a pioneering project that integrates Indigenous knowledge in the treatment of Chagas

The innovation lies in the coordination and participation of Indigenous leaders and local health authorities to implement the treatment strategies.

The innovation lies in the coordination and participation of Indigenous leaders and local health authorities to implement the treatment strategies

  • Stories
PaedsFilm2024-ValleduparColombia-202409-30

DNDi welcomes GHIT support for new collaboration with Shionogi to identify novel drug candidates for neglected Chagas disease

Shionogi and DNDi aim to identify novel hit series with potential to be developed into safer, more effective drugs for Chagas disease, a life-threatening illness with limited and suboptimal therapeutic options.
  • Press releases
Lab activities

DNDi welcomes GHIT support for new collaboration with Shionogi to identify novel drug candidates for neglected Chagas disease

Shionogi and DNDi aim to identify novel hit series with potential to be developed into safer, more effective drugs for Chagas disease, a life-threatening illness with limited and suboptimal therapeutic options.
  • Press releases
Lab activities

2024 R&D programmes in review: Chagas disease

DNDi and our partners are searching for shorter, safer, more effective treatments to stop a silent killer.  In the short term, we are working to develop improved treatment regimens with the existing drug benznidazole, reduce mother-to-child transmission, and help roll out ‘test-and-treat’ strategies to reach people living with Chagas disease in remote areas of Latin America. Our longer-term goal is to discover and develop entirely new drug candidates, with the aim of launching at least one Phase III trial by 2028.
  • News
Girl smiling

2024 R&D programmes in review: Chagas disease

DNDi and our partners are searching for shorter, safer, more effective treatments to stop a silent killer.  In the short term, we are working to develop improved treatment regimens with the existing drug benznidazole, reduce mother-to-child transmission, and help roll out ‘test-and-treat’ strategies to reach people living with Chagas disease in remote areas of Latin America. Our longer-term goal is to discover and develop entirely new drug candidates, with the aim of launching at least one Phase III trial by 2028.
  • News
Girl smiling

Please select a search term or criteria.

loading
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

Get in touch

Support us

Work with us